U. S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC
FORM 12b-25
SEC FILE NUMBER
NOTIFICATION OF LATE FILING
CUSIP NUMBER
00753W207
(Check One)
[ X ] Form 10-K and Form 10-KSB [ ] Form 20-F [ ] Form 11-K [ ]
Form 10-Q and Form 10-QSB
[ ] Form N-SAR
For Period Ended: June 30, 1998
[ ] Transition Report on form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended
______________________________________________________________________
_____________
Read Attached Instruction Sheet Before Preparing Form. Please Print or
Type.
Nothing in this form shall be construed to imply that the
commission has verified any
information contained herein.
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
Part I-Registrant Information
Full Name of Registrant
Former Name if Applicable
Advanced Medical Products, Inc.
Address of Principal Executive Office (Street & Number)
6 Woodcross Drive, Columbia, South Carolina 29212
City, State and Zip
Part II-Rules 12b-25 (b) and (c)
If the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable effort or
expense;
(b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof
will be filed on or before the fifteenth calendar day following the
prescribed due date; or the subject quarterly report or transition
report on Form 10-Q, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
Part III-Narrative
State below in reasonable detail the reasons why Form 10-K and Form
10-KSB, 20-F, 11-K, 10-Q and Form 10-QSB, N-SAR, or the transition
report or portion thereof could not be filed within the prescribed
period
Due to personnel changes within the accounting department, and
reliance on outside assistance, the books were not closed and the
detailed schedules for the audit were not prepared in time for the
outside independent auditors to start their field work on the original
schedule. The audit is now complete, and in internal partner review.
Filing of the 10KSB within the 15 days should be very doable.
Part IV-Other Information
(1) Name and telephone number of person to contact in regard to
this notification.
George L. Down (803) 407-3044
(Name)
(Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or
15(d) of the Securities Exchange Act of 1934 or section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for
such shorter period that the registrant was required to file such
report(s) been filed? If the Answer is no, identify reports(s).
[ ] Yes [ ] No
(3) Is it anticipated that any significant change in results of
operation from the corresponding period for the last fiscal year will
be reflected by the earnings statements to be included in the subject
report or portion thereof?
[ ] Yes [ ] No
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
Advanced Medical Products, Inc.
( Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Date September 29, 1998 By
Ronald G. Moyer, Chief Executive Officer
INSTRUCTIONS: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name
and title of the person signing the form shall be typed or printed
beneath the signature. If the statement is signed on behalf of the
registrant by an authorized representative (other than an executive
officer), evidence of the representative's authority to sign on behalf
of the registrant shall be filed with this form.
ATTENTION
Intentional misstatements or omissions of fact constitute
Federal Criminal Violations (See 18 U.S.C. 1001).
GENERAL INSTRUCTIONS
1. This form is required by Rule 12b-25 (17 CFR 240, 12b-25) of
the General Rules and Regulations under the Securities Exchange Act of
1934.
2. One signed original and four conformed copies of this form
and amendments thereto must be completed and filed with the Securities
and Exchange Commission, Washington, D.C. 20549, in accordance with
the Rule 0-3 of the General Rules and Regulations under the Act. The
information contained in or filed with the Form will be made a matter
of the public record in the Commission files.
3. A manually signed copy of the form and amendments thereto
shall be filed with each national securities exchange on which any
class of securities of the registrant is registered.
4. Amendments to the notifications must also be filed on Form
12b-25 by need not restate information that has been correctly
furnished. The form shall be clearly identified as an amended
notification.
5. Electronic Filers. This form shall not be used by
electronic filers unable to timely file a report solely due to
electronic difficulties. Filers unable to submit a report within the
time period prescribed due to difficulties in electronic filing should
comply with either Rule 201 or Rule 202 of Regulation S-T ( 232.201
or 232.202 of this chapter) or apply for an adjustment in filing
date pursuant to Rule 13(b) of Regulation S-T ( 232.13(b) of this
chapter).
BTCM:FORM 12B-25-RON MOYER.DOC
